{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:49:25Z","timestamp":1762523365062,"version":"build-2065373602"},"reference-count":20,"publisher":"Mattioli1885","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Introduction: Psoriasis, a chronic inflammatory dermatological condition, is marked by recurring periods of activity and quiescence. This persistent inflammation contributes to a range of associated health issues. The respiratory system relies on nasal mucociliary clearance as a fundamental defense mechanism. Mucociliary transport dysfunction is frequently observed in chronic inflammatory states. Objective: We aimed to determine the relationship between psoriasis and concomitant clinical conditions and NMCT Method: We conducted a study to evaluate nasal mucociliary clearance time (NMCT) in 34 individuals diagnosed with psoriasis and a control group of 35 healthy individuals. Results: Our results revealed a statistically significant prolongation of NMCT in the psoriasis group (11.26 \u00b1 2 minutes) compared to the control group (9.2 \u00b1 1.85 minutes, p&lt;0.001). Moreover, a positive correlation was identified between NMCT and both the duration of psoriasis and the Psoriasis Area and Severity Index (PASI). This suggests that impaired nasal mucociliary clearance in individuals with psoriasis, especially those with more severe disease, may elevate their vulnerability to infections of the sinuses and nasal passages. Conclusion: This highlights the need to consider strategies for enhancing mucociliary function in this patient population.<\/jats:p>","DOI":"10.5826\/dpc.1502a5014","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:11:00Z","timestamp":1747120260000},"page":"5014","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Nasal Mucociliary Activity in Patients With Psoriasis Vulgaris"],"prefix":"10.5826","volume":"15","author":[{"given":"Mehmet Akif","family":"Dundar","sequence":"first","affiliation":[{"name":"Necmettin Erbakan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selami Aykut","family":"Temiz","sequence":"additional","affiliation":[{"name":"Necmettin Erbakan Univercity Meram Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail Hakk\u0131","family":"Tuncez","sequence":"additional","affiliation":[{"name":"Konya ProvincialHealthDirectorate, Department of PublicHealth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Emre","sequence":"additional","affiliation":[{"name":"F\u0131rat UniversityMedicalFaculty, Department of Anatomy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadettin","family":"Emre","sequence":"additional","affiliation":[{"name":"F\u0131rat UniversityMedicalFaculty, Department of EarNoseThroat"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recep","family":"Dursun","sequence":"additional","affiliation":[{"name":"Necmettin Erbakan University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27750","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"10.5826\/dpc.1502a5014_ref1","doi-asserted-by":"crossref","unstructured":"\u00d6zer \u0130, Temiz SA, Ataseven A, et al. Is prenatal testosterone-estrogen balance associated with psoriasis? Dermatol Ther. 2020;33(6):e14213. DOI: 10.1111\/dth.14213. PMID: 32820834","DOI":"10.1111\/dth.14213"},{"key":"10.5826\/dpc.1502a5014_ref2","doi-asserted-by":"crossref","unstructured":"Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377-390. DOI: 10.1016\/j.jaad.2016.07.064. PMID: 28212759","DOI":"10.1016\/j.jaad.2016.07.064"},{"key":"10.5826\/dpc.1502a5014_ref3","doi-asserted-by":"crossref","unstructured":"Koparal M, Kurt E, Altuntas EE, Dogan F. Assessment of mucociliary clearance as an indicator of nasal function in patients with COVID-19: a cross-sectional study. Eur Arch Otorhinolaryngol. 2021;278:1863-1868. DOI: 10.1007\/s00405-020-06457-y. PMID: 33185743","DOI":"10.1007\/s00405-020-06457-y"},{"key":"10.5826\/dpc.1502a5014_ref4","unstructured":"Kesimci E, Bercin S, Kutluhan A, et al. Volatile anesthetics and mucociliary clearance. Minerva Anestesiol. 2008;74(4):107-111. PMID: 18354365"},{"key":"10.5826\/dpc.1502a5014_ref5","unstructured":"Petrov VV. Age features of mucociliary system the mucous membrane of the nasal cavity of the human. Adv Gerontol. 2016;29(3):507-510. DOI: 10.1134\/s2079057016030167. PMID: 28525702"},{"key":"10.5826\/dpc.1502a5014_ref6","doi-asserted-by":"crossref","unstructured":"Prasetyo A, Sadhana U, Budiman J. Nasal mucociliary clearance in smokers: a systematic review. Int Arch Otorhinolaryngol. 2021;25:160-169. DOI: 10.1055\/s-0040-1702965. PMID: 33542766","DOI":"10.1055\/s-0040-1702965"},{"key":"10.5826\/dpc.1502a5014_ref7","doi-asserted-by":"crossref","unstructured":"Kahraman ME, Y\u00fcksel F, \u00d6zbu\u011fday Y. The relationship between Covid-19 and mucociliary clearance. Acta Otolaryngol. 2021;141(11):989-993. DOI: 10.1080\/00016489.2021.1991592. PMID: 34694199","DOI":"10.1080\/00016489.2021.1991592"},{"key":"10.5826\/dpc.1502a5014_ref8","doi-asserted-by":"crossref","unstructured":"Yue WL. Nasal mucociliary clearance in patients with diabetes mellitus. J Laryngol Otol. 1989;103(9):853-855. DOI: 10.1017\/S0022215100110291. PMID: 2584876","DOI":"10.1017\/S0022215100110291"},{"key":"10.5826\/dpc.1502a5014_ref9","doi-asserted-by":"crossref","unstructured":"de Oliveira-Maul JP, de Carvalho HB, Goto DM, et al. Aging, diabetes, and hypertension are associated with decreased nasal mucociliary clearance. Chest. 2013;143(4):1091-1097. DOI: 10.1378\/chest.12-1183. PMID: 23100111","DOI":"10.1378\/chest.12-1183"},{"key":"10.5826\/dpc.1502a5014_ref10","doi-asserted-by":"crossref","unstructured":"Comba A, Atan D. Evaluation of nasal mucociliary clearance time in children with celiac disease. Int J Pediatr Otorhinolaryngol. 2020;133, 109936. DOI: 10.1016\/j.ijporl.2020.109936. PMID: 32088546","DOI":"10.1016\/j.ijporl.2020.109936"},{"key":"10.5826\/dpc.1502a5014_ref11","doi-asserted-by":"crossref","unstructured":"Ozbay I, Kucur C, Temizturk F, et al. Assessment of nasal mucociliary activity in patients with Beh\u00e7et\u2019s disease. J Laryngol Otol. 2016;130(4):348-351. DOI: 10.1017\/S0022215116000207. PMID: 26841706","DOI":"10.1017\/S0022215116000207"},{"key":"10.5826\/dpc.1502a5014_ref12","doi-asserted-by":"crossref","unstructured":"Kucur C, Ozbay I, Gulcan E, et al. Evaluation of nasal mucociliary activity in patients with chronic renal failure. Eur Arch Otorhinolaryngol. 2016;273:1167-1171. DOI: 10.1007\/s00405-015-3712-8. PMID: 26162451","DOI":"10.1007\/s00405-015-3712-8"},{"key":"10.5826\/dpc.1502a5014_ref13","doi-asserted-by":"crossref","unstructured":"Deniz M, Gultekin E, Ciftci Z, et al. Nasal Mucociliary Clearance in Obstructive Sleep Apnea Syndrome Patients. Am J Rhinol Allergy. 2014;28(5):e178\u2013e180. DOI: 10.2500\/ajra.2014.28.4094. PMID: 25198014","DOI":"10.2500\/ajra.2014.28.4094"},{"key":"10.5826\/dpc.1502a5014_ref14","doi-asserted-by":"crossref","unstructured":"Joel MZ, Fan R, Damsky W, Cohen JM. Psoriasis associated with asthma and allergic rhinitis: a US-based cross-sectional study using the All of US Research Program. Arch Dermatol Res. 2023;315(6):1823-1826. DOI: 10.1007\/s00403-023-02539-z. PMID: 36707438","DOI":"10.1007\/s00403-023-02539-z"},{"key":"10.5826\/dpc.1502a5014_ref15","doi-asserted-by":"crossref","unstructured":"Andersen YMF, Egeberg A, Gislason GH, et al. Burden of respiratory comorbidities in patients with atopic dermatitis and psoriasis. Br J Dermatol. 2017;177(4):e145\u2013e146. DOI: 10.1111\/bjd.15489. PMID: 28334421","DOI":"10.1111\/bjd.15489"},{"key":"10.5826\/dpc.1502a5014_ref16","doi-asserted-by":"crossref","unstructured":"Branisteanu DE, Nicolescu AC, Branisteanu DC, et al. Cardiovascular comorbidities in psoriasis. Exp Ther Med. 2022;23(2):1-5. DOI: 10.3892\/etm.2021.11075. PMID: 35069833","DOI":"10.3892\/etm.2021.11075"},{"key":"10.5826\/dpc.1502a5014_ref17","doi-asserted-by":"crossref","unstructured":"Rademaker M, Agnew K, Anagnostou N, et al. Psoriasis and infection. A clinical practice narrative. Australas J Dermatol. 2019;60(2):91-98. DOI: 10.1111\/ajd.12895. PMID: 30079566","DOI":"10.1111\/ajd.12895"},{"key":"10.5826\/dpc.1502a5014_ref18","doi-asserted-by":"crossref","unstructured":"Yiu ZZ, Exton LS, Jabbar-Lopez Z, et al. Risk of serious infections in patients with psoriasis on biologic therapies: a systematic review and meta-analysis. J Invest Dermatol. 2016;136(8):1584-1591. DOI: 10.1016\/j.jid.2016.03.035. PMID: 27085754","DOI":"10.1016\/j.jid.2016.03.035"},{"key":"10.5826\/dpc.1502a5014_ref19","doi-asserted-by":"crossref","unstructured":"Kalb RE, Fiorentino DF, Lebwohl MG, et al. Risk of serious infection with biologic and systemic treatment of psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA Dermatol. 2015;151(9):961-969. DOI: 10.1001\/jamadermatol.2015.0718. PMID: 25970800","DOI":"10.1001\/jamadermatol.2015.0718"},{"key":"10.5826\/dpc.1502a5014_ref20","unstructured":""}],"container-title":["Dermatology Practical &amp; Conceptual"],"original-title":[],"link":[{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/5014\/3049","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/5014\/3503","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/download\/5014\/3049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:43:28Z","timestamp":1762523008000},"score":1,"resource":{"primary":{"URL":"https:\/\/dpcj.org\/index.php\/dpc\/article\/view\/5014"}},"subtitle":["Nasal mucociliary activity in patients with psoriasis"],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5826\/dpc.1502a5014","relation":{"has-manifestation":[{"id-type":"other","id":"1-79-5014-g3049","asserted-by":"subject"},{"id-type":"other","id":"1-79-5014-g3503","asserted-by":"subject"}],"is-part-of":[{"id-type":"doi","id":"10.5826\/dpc.v15i2","asserted-by":"subject"}]},"ISSN":["2160-9381"],"issn-type":[{"type":"electronic","value":"2160-9381"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"article-number":"15"}}